Elizabeth Litten and Marilou Watson Host Members of the African Women’s Entrepreneurship ProgramAugust 27, 2015 – Press Releases
Elizabeth G. Litten and Marilou E. Watson, partners at Fox Rothschild LLP, hosted three businesswomen and an interpreter from Tunisia, Egypt and Morocco as a part of the African Women’s Entrepreneurship Program (AWEP) under the U.S. Department of State’s International Visitor Leadership Program.
AWEP’s Philadelphia event was organized through Citizens Diplomacy International of Philadelphia (CDI), of which Litten serves on the board of directors. CDI is a unique “citizen diplomacy” network of 95 Councils in 48 states that receive established and emerging leaders who visit the United States from more than 120 countries as guests of our government.
“I was honored to be able to host this historic event and to help start an important conversation about women and economic growth in our country,” said Litten. “These women are truly an inspiration, and meetings like this are an important factor in our efforts to reduce the gender gap and gain equality for women in the workforce.”
According to AWEP, an outreach, education and engagement initiative that targets African women entrepreneurs to promote business growth, “Women make up 50 percent of the global population, 40 percent of the global workforce, yet only own about one percent of the world’s wealth.”
Active in the public and private sectors, Litten serves as national and regional counsel to hospital systems, health care facilities, health plans, technology companies, physicians groups and a wide range of other health care-related organizations and entities. With more than 20 years of experience in the industry, she has become a go-to source for regulatory health care matters throughout the nation.
An industry veteran with more than two decades of experience, Watson, co-chair of the Life Sciences Practice and former co-chair of Fox’s Diversity Initiative, focuses her practice on all aspects of intellectual property law, with particular emphasis on foreign and domestic patent prosecution, client counseling, infringement analysis, patent invalidity and freedom to operate studies and Hatch-Waxman issues related to ANDA filings, licensing, due diligence and divestiture matters in the chemical and pharmaceutical arts.